Improving Mental Health Among the LGBTQ+ Community

Purpose

The overall aim of this program of research is to improve the mental health of people who identify as LGBTQ+ by increasing their social support through a brief intervention. The purpose of the proposed project is to establish the effectiveness of our empirically-supported, brief acceptance-based behavioral therapy (ABBT). To achieve the specific aims, the investigators will conduct a fully-powered, randomized clinical trial (n=240) with two treatment arms: treatment-as-usual (TAU) vs. ABBT.

Conditions

  • Anxiety
  • Depression

Eligibility

Eligible Ages
Over 18 Years
Eligible Genders
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Present to recruitment clinic for any type of clinical care - Identify as LGBTQ+ - Self-reported ≥ mild anxiety and/or depressive symptoms, based on the GAD-7 and PHQ-9 - 18 years or older - Ability to speak and read English

Exclusion Criteria

  • None

Study Design

Phase
Phase 2
Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel Assignment
Intervention Model Description
This is a 2-arm RCT.
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)
Masking Description
Blinded raters will conduct interviewer-rated assessments of anxiety and depression (primary outcomes)

Arm Groups

ArmDescriptionAssigned Intervention
Experimental
Acceptance-Based Behavior Therapy (ABBT) 		The 2-session ABBT will be delivered remotely or in-person, depending on preference.
  • Behavioral: Acceptance-Based Behavior Therapy (ABBT)
    In the first session, the interventionist will introduce the concept of acceptance and its possible benefits in the context of life values and participant-identified challenges related to the COVID-19 pandemic, mental health, and social support. Interventionists will help participants identify potential challenges to acceptance. At the second session, participants will practice acceptance-based coping skills and a social support behavioral plan will be developed. These discussions will help the participant clarify how best to align their values with decisions on how to manage their mental health and social support in the context of the COVID-19 pandemic.
Other
Treatment-as-Usual (TAU) 		Control participants will receive the currently recommended best practices of care at the recruitment site.
  • Other: Treatment-as-Usual (TAU)
    TAU includes brief mental health screening, consultation with providers, and referrals to psychotherapy and/or psychiatric medication.

Recruiting Locations

Brown University
Providence, Rhode Island 02912
Contact:
Ethan Moitra
401-444-1949
ethan_moitra@brown.edu

More Details

NCT ID
NCT05540067
Status
Recruiting
Sponsor
Brown University

Study Contact

Ethan Moitra, Ph.D.
(401) 444-1949
ethan_moitra@brown.edu

Detailed Description

During the COVID-19 pandemic, up to 81% of adults in the United States experienced worsening mental health. A major cause was the social isolation triggered by the pandemic due to quarantining, loss of family or friends, and loss of work. For individuals who lost social connections or were unable to adapt to maintain their connections, social support decreased and loneliness worsened, putting them at much higher risk for anxiety and depressive symptoms. Importantly, people who identify as LGBTQ+ have been particularly affected by the social isolation caused by the pandemic and were already at much higher risk of social isolation, loneliness, and mental illness, including suicidality, before the pandemic. The objective of this R01 fully-powered trial is to examine the effectiveness of a brief acceptance-based behavioral telehealth intervention (ABBT) to improve mental health during the COVID-19 pandemic by strengthening social support among LGBTQ+ individuals. The aims of this proposal are: (1) to examine the effectiveness of ABBT in reducing mental health morbidity by conducting a fully-powered, RCT (n=240) of ABBT vs. Treatment-as-Usual; and, (2) to examine potential mediators and moderators of ABBT treatment effects. Primary outcomes will be anxiety and depressive symptoms.